Sean Landrette

Sean Landrette is the Director of Biology at AI Therapeutics. His doctoral training was in the Program in Gene Function and Expression at the University of Massachusetts Medical School under Lucio Castilla where he worked on dissecting the molecular mechanisms driving acute myeloid leukemia. He next pursued postdoctoral research as an American Cancer Society Fellow at the Yale School of Medicine under Tian Xu where he developed forward genetic tools to identify drivers of cancer and drug resistance. Dr. Landrette joined AI Therapeutics in 2013 and has worked on the development and translation of assets across oncology and rare disease indications.